Liquidia

37.91
Open
36.95
Market Cap
3.32B+
High
37.83
Low
36.54
Close
37.68
Volume
786.68K+
P/E Ratio
-47.10
Div/Yield
0.00%

About Liquidia

Liquidia Corporation 是一家生物製藥公司,開發、製造和商業化各種產品以滿足美國未滿足的患者需求。其候選產品包括 YUTREPIA,一種用於治療肺動脈高壓的曲前列環素吸入乾粉製劑。它還在美國分銷通用曲前列環素注射劑。 Liquidia Corporation 成立於 2004 年,總部位於北卡羅來納州的莫里斯維爾。

如何購買 Liquidia (LQDA)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 LQDA

購買 LQDA

透過 RockFlow App 或網頁端搜尋 LQDA,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.